Can you help me feel less exhausted all the time?

Journal of Clinical Oncology

Volumn 31, Issue 25, 2013, Pages 3056-3060

  De Raaf, Pleun J ^a   Van Der Rijt, Carin C D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CETUXIMAB; CORTICOTROPIN RELEASING FACTOR; IRINOTECAN; OXALIPLATIN; CENTRAL STIMULANT AGENT; DEXAMETHASONE; METHYLPHENIDATE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; ARTICLE; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CASE REPORT; DYSPNEA; EXERCISE; FEMALE; HUMAN; IMMOBILITY; LIVER METASTASIS; LUNG METASTASIS; MEDICAL HISTORY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NAUSEA; PALLIATIVE THERAPY; PATIENT; PHYSICAL EXAMINATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RISK FACTOR; TREATMENT DURATION; VOMITING; FATIGUE; RECTUM TUMOR;

CENTRAL NERVOUS SYSTEM STIMULANTS; DEXAMETHASONE; FATIGUE; FEMALE; HUMANS; METHYLPHENIDATE; MIDDLE AGED; RECTAL NEOPLASMS;

EID: 84886579772     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.3403     Document Type: Article

References (44)

1. Teunissen SC, Wesker W, Kruitwagen C, et al: Symptom prevalence in patients with incurable cancer: A systematic review. J Pain Symptom Manage 34:94-104, 2007.
2. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Cancer-related fatigue, version I.2013. http://www.nccn.org/professionals/physician-gls/pdf/fatigue.pdf.
3. Radbruch L, Strasser F, Elsner F, et al: Fatigue in palliative care patients: An EAPC approach. Palliat Med 22:13-32, 2008.
4. Walsh D, Donnelly S, Rybicki L: The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1, 000 patients. Support Care Cancer 8:175-179, 2000.
5. Echteld MA, Passchier J, Teunissen S, et al: Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer 43:1030-1036, 2007.
6. Hauser K, Rybicki L, Walsh D: What's in a name? Word descriptors of cancer-related fatigue. Palliat Med 24:724-730, 2010.
7. Hwang SS, Chang VT, Rue M, et al: Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage 26:604-614, 2003.
8. Minton O, Strasser F, Radbruch L, et al: Identification of factors associated with fatigue in advanced cancer: A subset analysis of the European Palliative Care Research Collaborative computerized symptom assessment data set. J Pain Symptom Manage 43:226-235, 2012.
9. Okuyama T, Akechi T, Shima Y, et al: Factors correlated with fatigue in terminally ill cancer patients: A longitudinal study. J Pain Symptom Manage 35:515-523, 2008.
10. Yennurajalingam S, Palmer JL, Zhang T, et al: Association between fatigue and other cancerrelated symptoms in patients with advanced cancer. Support Care Cancer 16:1125-1130, 2008.
11. Chen E, Nguyen J, Cramarossa G, et al: Symptom clusters in patients with advanced cancer: Sub-analysis of patients reporting exclusively nonzero ESAS scores. Palliat Med 26:826-833, 2012.
12. Cheung WY, Le LW, Zimmermann C: Symptom clusters in patients with advanced cancers. Support Care Cancer 17:1223-1230, 2009.
13. Fan G, Filipczak L, Chow E: Symptom clusters in cancer patients: A review of the literature. Curr Oncol 14:173-179, 2007.
14. Laird BJ, Scott AC, Colvin LA, et al: Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage 42:1-11, 2011.
15. Yennurajalingam S, Kwon JH, Urbauer DL, et al: Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care 7:1-8, 2013.
16. Miller AH, Ancoli-Israel S, Bower JE, et al: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971-982, 2008.
17. Headley JA, Ownby KK, John LD: The effect of seated exercise on fatigue and quality of life inwomen with advanced breast cancer. Oncol Nurs Forum 31:977-983, 2004.
18. Adamsen L, Quist M, Andersen C, et al: Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Randomised controlled trial. BMJ 339:b3410, 2009.
19. Oldervoll LM, Loge JH, Lydersen S, et al: Physical exercise for cancer patients with advanced disease: A randomized controlled trial. Oncologist 16:1649-1657, 2011.
20. Ream E, Richardson A, Alexander-Dann C: Supportive intervention for fatigue in patients undergoing chemotherapy: A randomized controlled trial. J Pain Symptom Manage 31:148-161, 2006.
21. Armes J, Chalder T, Addington-Hall J, et al: A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer 110:1385-1395, 2007.
22. de Raaf PJ, de Klerk C, Timman R, et al: Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: A randomized controlled trial. J Clin Oncol 31:716-723, 2013.
23. Morrow GR, Hickok JT, Roscoe JA, et al: Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21: 4635-4641, 2003.
24. Bruera E, El Osta B, Valero V, et al: Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475-3481, 2007.
25. Beijer S, Hupperets PS, van den Borne BE, et al: Randomized clinical trial on the effects of adenosine 5-triphosphate infusions on quality of life, functional status, and fatigue in preterminal cancer patients. J Pain Symptom Manage 40:520-530, 2010.
26. Cruciani RA, Zhang JJ, Manola J, et al: L-carnitine supplementation for the management of fatigue in patients with cancer: An Eastern Cooperative Oncology Group phase III, randomized, doubleblind, placebo-controlled trial. J Clin Oncol 30: 3864-3869, 2012.
27. Bruera E, Valero V, Driver L, et al: Patientcontrolled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073-2078, 2006.
28. Butler JM Jr, Case LD, Atkins J, et al: A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 69:1496-1501, 2007.
29. Kerr CW, Drake J, Milch RA, et al: Effects of methylphenidate on fatigue and depression: A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 43:68-77, 2012.
30. Moraska AR, Sood A, Dakhil SR, et al: Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancerrelated fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol 28:3673- 3679, 2012.
31. Auret KA, Schug SA, Bremner AP, et al: A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage 37:613-621, 2009.
32. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al: Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebocontrolled trial in patients with advanced cancer. J Clin Oncol 31:3076-3082, 2013.
33. Cramp F, Daniel J: Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2:CD006145, 2008.
34. Oldervoll LM, Loge JH, Paltiel H, et al: The effect of a physical exercise program in palliative care: A phase II study. J Pain Symptom Manage 31:421-430, 2006.
35. Goedendorp MM, Gielissen MF, Verhagen CA, et al: Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 1:CD006953, 2009.
36. Godino C, Jodar L, Duran A, et al: Nursing education as an intervention to decrease fatigue perception in oncology patients. Eur J Oncol Nurs 10:150-155, 2006.
37. Minton O, Stone P, Richardson A, et al: Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev 1:CD006704, 2008.
38. Minton O, Richardson A, Sharpe M, et al: Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev 7:CD006704, 2010.
39. Tonia T, Bohlius J: Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients. Cancer Treat Res 157:217-238, 2011.
40. Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985.
41. Hanks GW, Trueman T, Twycross RG: Corticosteroids in terminal cancer-a prospective analysis of current practice. Postgrad Med J 59:702-706, 1983.
42. Hempen C, Weiss E, Hess CF: Dexamethasone treatment in patients with brain metastases and primary brain tumors: Do the benefits outweigh the side-effects? Support Care Cancer 10:322-328, 2002.
43. Bennett MI, Flemming K, Closs SJ: Education in cancer pain management. Curr Opin Support Palliat Care 5:20-24, 2011.
44. Oldenmenger WH, Sillevis Smitt PA, van Dooren S, et al: A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal. Eur J Cancer 45:1370-1380, 2009.